ProfessorAlison Yung

Professor (Clinical Research)

Faculty of Health/School of Medicine/Institute for Mental and Physical Health and Clinical Translation

  • Professor (Clinical Research)
    Faculty of Health/School of Medicine/Institute for Mental and Physical Health and Clinical Translation
  • +61 3 522 78509 (Work)
  • HERB, Health, Education and Research Building (HERB), Level 1, 285 Ryrie Street, Geelong

BIO

Alison Yung's qualifications are: MBBS, University of Melbourne 1986; Master
of Psychological Medicine, Monash University 1994; Fellowship of the Royal
Australian and New Zealand College of Psychiatrists, 1994; MD, University of
Melbourne 2004; Graduate Diploma in Epidemiology and Biostatistics, University
of Melbourne. 2004; Member, Royal College of Psychiatrists, 2013; Full
Registration, General Medical Council, UK, 2013.

ORCID ID: 0000-0002-0401-9791

Web of Science Researcher ID: N-7413-2019

Current positions:

NHMRC Principal Research Fellow and Professor, Institute for Mental and
Physical Health and Clinical Translation (IMPACT), Deakin University

Consultant Psychiatrist, Barwon Health, Mental Health, Drugs and Alcohol
Services

Honorary appointments:

Past President International Early Psychosis Association

Alison Yung's research has resulted in reform in the delivery of mental health
services for young people thought to be at high risk of schizophrenia. In 1994
in Melbourne, Australia, she established the first clinic for individuals
identified as being at imminent high risk of psychotic disorder ("Ultra High
Risk" - UHR) in the world. Based on this service model and the UHR criteria,
similar services have been established both nationally and internationally,
including in the UK, Europe, North and South America and Asia. These services
aim to prevent or delay the onset of psychosis or minimise its impact. The
instrument that she developed to assess UHR status, the Comprehensive
Assessment of At Risk Mental States (CAARMS), has been translated into 18
languages. She was instrumental in ensuring that the Attenuated Psychosis
Syndrome (based on the UHR criteria) was included in the DSM5 as a "condition
for further study".

Prizes and awards:

2026: RANZCP Senior Research Award


2020: Outstanding Translational Research Award, Schizophrenia International
Research Society

2015-20215 Highly Cited Researcher

2019: Founders' Medal, Society for Mental Health Research

2018: National Institute of Health Research Senior Investigator award

2018: NHMRC Principal Research Fellowship

2016: Supervisor of the Year, Faculty of Biology, Medicine and Health,
University of Manchester

2014-2015: Named as One of the World's Most Influential Scientific Minds by
Thomson Reuters

2010: Richard J Wyatt Award, International Early Psychosis Association

2009: Lilly Oration Award, Australasian Society of Psychiatric Research

2003: NARSAD independent investigator award

Research Groups
Theme Lead: Mental Health and Neurosciences, IMPACT, Deakin University

Collaborator: Food and Mood group, IMPACT, Deakin University

DEAKIN UNIVERSITY CURRENT APPOINTMENT

  • Professor (Clinical Research)
    Deakin University, School of Medicine

ACADEMIC POSITIONS

  • Emeritus Professor
    University of Manchester, School of Health Sciences, Manchester, United Kingdom1 Sep 2012 - 1 Sep 2048

FIELDS OF RESEARCH

  • Clinical sciences
  • Clinical and health psychology
  • Neurosciences

AVAILABILITY FOR SUPERVISION

  • Masters by Research and PhD supervision

AREA/FACULTY

  • Faculty of Health

DEPARTMENT/SCHOOL/INSTITUTE/DISCIPLINE

  • School of Medicine

SPECIALIST RESEARCH GROUP

  • Institute for Mental and Physical Health and Clinical Translation